This is a working overview of post-marketing surveillance, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-09-24 and is reviewed periodically as new material appears.
Verification of a purchased sample requires documentation linking a batch to a certificate of analysis, and that document should be read for the methods used rather than the headline purity figure. A single chromatographic percentage does not establish identity. Independent laboratories can perform identity and content assays, but no such test establishes that a product is suitable for human use. Claims about efficacy rest largely on small, early studies rather than on replicated controlled trials, and that gap remains open.
Identity testing for a cyclic peptide of this size usually relies on reversed-phase high-performance liquid chromatography coupled to mass spectrometry. The mass spectrum confirms molecular weight, while the chromatographic trace indicates the proportion of related impurities. Tandem mass spectrometry can provide sequence-level information when fragmentation data are compared against a reference standard. Nuclear magnetic resonance is sometimes used to confirm the lactam bridge, although it requires more material and greater operator expertise than routine chromatographic methods.
Reversed-phase high-performance liquid chromatography is the routine method for purity assessment. Peptides absorb near 214 nm because of the peptide bond, and a gradient of acetonitrile in water separates the intact peptide from deletion sequences, oxidised products, and earlier-eluting fragments at neutral pH. Electrospray ionisation mass spectrometry provides an orthogonal check: the measured mass must agree with the theoretical value. Amino acid analysis and peptide mapping confirm structure but are used less often. Reference standards remain scarce because the peptide is not described in any pharmacopoeia.
Regulatory treatment varies by country. In the United States the peptide is not approved as a medicine, and products offered for human use may be treated as unapproved new drugs; some states also restrict sale. Australia, the United Kingdom, and European Union member states apply comparable restrictions to unapproved peptide products. Border agencies have seized shipments labelled as research chemicals. Classification may change over time, and the legal position for personal importation is not clearly settled in most published guidance.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white solid | Lyophilised cake or flake |
| Solubility class | Soluble in water and aqueous buffer | Also soluble in some polar organic solvents |
| Typical storage temperature | Minus 20 degrees Celsius or below | Desiccated and protected from light |
| Typical analytical method | LC-MS/MS | Reversed-phase separation with mass detection |
| Molecular formula | C50H69N15O9 | Free base; salt forms differ |
Melanotan-2 has not received marketing authorisation from major regulatory agencies for any therapeutic indication. Several jurisdictions classify it as a prescription-only medicine or a controlled substance when supplied for human use. Because approved products do not exist, material sold online usually sits outside pharmaceutical supply chains and formal quality oversight. Regulators have issued public notices describing the compound as unapproved. Enforcement varies, and the legal position differs between countries, which complicates any single general statement about its status.
Scientific discussion of Melanotan-2 spans pharmacology, dermatology, and public-health literature. Laboratory studies examine its receptor binding and cellular effects, while clinical reports describe outcomes observed after unregulated use. These two bodies of work differ in rigour and intent. Peer-reviewed trials of the compound as a medicine are limited, so much of the available information comes from case reports and surveillance data. Authors frequently note the gap between experimental findings and real-world use.
Solid peptide kept dry at minus twenty degrees Celsius, shielded from light and moisture, is generally considered stable for extended periods. Solutions are divided into single-use aliquots and held at minus twenty or minus eighty degrees Celsius, because repeated freeze-thaw cycles promote aggregation and loss of material to container surfaces. Hydrolysis of the backbone and oxidation of tryptophan are the principal degradation routes in aqueous solution, and both accelerate at ambient temperature. Hygroscopic uptake after a vial is opened can also shift the actual mass weighed, which affects any concentration calculated from it.
Routine characterisation relies on reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometres, using a C18 column and a water-acetonitrile gradient containing trifluoroacetic acid. Electrospray ionisation mass spectrometry confirms the expected molecular mass and can reveal truncated or oxidised by-products that co-elute poorly. Sequence and stereochemistry require additional work, such as peptide mapping or amino acid analysis, because a chromatographic purity figure alone does not distinguish a diastereomer from the target peptide. Independent testing of research-grade material frequently shows measured content below the stated label, so a certificate of analysis is best read together with the method that produced it.
Melanotan-2 is handled in the laboratory as a lyophilised powder that dissolves readily in water, dimethyl sulfoxide and dimethylformamide, with limited solubility in ethanol. Stock solutions prepared in an organic solvent often precipitate when diluted into aqueous buffer, so gradual dilution with mixing is standard practice. The peptide carries a tryptophan residue and a histidine residue, both sensitive to oxidation and to alkaline conditions. Working solutions are therefore kept near neutral to slightly acidic pH, protected from light, and consumed within the same working session whenever that is practical.
Melanotan-2 appears on the World Anti-Doping Agency prohibited list within the peptide hormone class, and several national regulators treat it as an unapproved prescription substance. Some countries restrict importation or sale for personal use. Because the compound is widely traded as a research chemical, the practical legal picture differs between jurisdictions and shifts over time. Human safety data covering long periods are limited, and whether repeated pigmentation changes carry any lasting risk to melanocytes remains an open question.
Freeze-dried melanotan-2 is normally kept as a desiccated powder at minus twenty degrees Celsius or lower, shielded from light and moisture. Peptides of this size degrade through hydrolysis, oxidation and deamidation, and each pathway accelerates as temperature and water activity rise. Repeated freeze-thaw cycles promote aggregation and loss of material, so aliquoting a stock solution before freezing is standard laboratory practice. Once dissolved, the solution is markedly less stable than the powder. In laboratory work, solutions are generally refrigerated and used within days rather than kept for months.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated or oxidised impurities. Mass spectrometry, most often coupled to liquid chromatography, confirms molecular mass and detects substitutions that chromatography alone may miss. Amino acid analysis and peptide mapping supply additional structural evidence, while nuclear magnetic resonance is reserved for full structural confirmation. Laboratories that examine samples sold online report wide variation in actual content, with some vials containing little or none of the labelled material.
Identification in laboratories relies on reversed-phase liquid chromatography coupled with tandem mass spectrometry, with product-ion spectra compared against a certified reference standard. High-resolution mass spectrometry supplies accurate mass confirmation, and peptide mapping after enzymatic digestion separates melanotan II from closely related analogues. Quantitation of seized material is complicated by unknown counter-ions and residual trifluoroacetate left from purification. Immunoassays raised against alpha-melanocyte-stimulating hormone can cross-react, so chromatographic confirmation is normally required. Urinary detection windows are short, and reported limits of detection differ substantially between laboratories.
Melanotan II holds no marketing authorisation from the Food and Drug Administration, the European Medicines Agency, the UK Medicines and Healthcare products Regulatory Agency or Australia's Therapeutic Goods Administration. Products sold under that name are treated as unapproved new drugs, and their sale or import is prohibited in several jurisdictions. Other countries classify the peptide as a prescription-only medicine or place it among controlled substances, so the legal position changes with the destination market. No pharmacopoeial monograph supplies an official specification, because the material is not a licensed pharmaceutical. Consequently, products offered online are not manufactured to a shared public standard.
Kruja, headquartered at the tekke of Fushë-Krujë Elbasan, headquartered at the tekke of Krastë, Dibër Korça, headquartered at the tekke of Melçan Gjirokastra, headquartered at the tekke of Asim Baba Prishta, representing Berat and part of Përmet Vlora, headquartered at the tekke of Frashër National headquarters in other countries are located in:
In 1974, Prince George's County became the nation's largest school district mandated to implement a busing plan to address segregation. Despite the county's over 80% white demographic at the time, specific communities near Washington, D.C. had denser black populations. Although school boundaries were based on communities, the NAACP contended they mirrored segregated housing patterns. Consequently, a federal court mandated a school busing plan. A 1974 Gallup poll indicated that 75% of the county opposed forced busing, with just 32% of black respondents in favor. The court-mandated busing commenced abruptly mid-school year, excluding final-year high school students. This swift transition disturbed regular school activities and affected family life due to altered schedules, transportation challenges, and disrupted extracurriculars. By 2001, the court concluded that segregation had been sufficiently addressed. The busing order ended, and neighborhood-centric school boundaries were reinstated.
Shimadzu Corp. released the MALDI digital ion trap mass spectrometer MALDImini-1 in 2019. Having a foot print of a A3 paper, the MALDI mass spectrometer covered an impressive mass range up to 70,000 Th and a MSn mass rang to 5,000 Th. Tandem mass analysis function up to MS3 is available, which allows researchers to carry out comprehensive structural analyses, such as direct glycopeptide analysis, post translational modification analysis, and branched glycan structural analysis.
=== Setting and characters === Whereas Half-Life was set in a single location, the Black Mesa research facility, Valve wanted "a much more epic and global feel" for the sequel. One concept had the player teleporting between planets, which was discarded as it would make continuity between levels difficult. At the suggestion of the art director, Viktor Antonov, who was Bulgarian, the team settled on a city in an Eastern European location. In this early concept, players would start at the boarding of the Borealis, an icebreaker bound for the city. Nova Prospekt was conceived as a small rail depot built on an old prison in the wasteland and grew from a stopping-off point to the destination itself. After observing how players had connected to minor characters in Half-Life, the team developed the characterization, with more detailed character models and realistic animation. The animator Ken Birdwell studied the work of the psychologist Paul Ekman, who had researched how facial muscles express emotion. The writer Marc Laidlaw created family relationships between the characters, saying that it was a "basic dramatic unit everyone understands" but rarely used in games. The voice cast included Louis Gossett Jr., Robert Guillaume and Robert Culp.
Sources: en.wikipedia.org
=== Healthcare === In July 2018, Premier Ford named Rueben Devlin, an orthopedic surgeon who was CEO of Toronto's Humber River Hospital and a "key Tory adviser" and former Ontario PCs president—to a $348,000 a year three-year appointment on the Council on Improving Healthcare and Ending Hallway Medicine, to curb hospital overcrowding. Devlin is the Ford family's "closest health-care adviser." Health costs in Ontario were over $60 billion annually, according to TVO's Steve Paikin. Devlin is tasked with the selection of the other Council members, and with "ending hallway medicine, dental care for seniors, improved mental-health services), all while ensuring stable, long-term funding for the system—Premier Ford's election promises. Since coming into power in June 2018, Premier Ford's government put an approved injection site in Toronto—and several other places—on pause while Health Minister Christine Elliott studied the issue. In February 2019, the Ontario NDP said that two sets of leaked documents show that the Ford government was creating a health "super agency" that "would be in charge of managing health services, quality improvement, patient relations, digital health and tissue donation and transplants, among other responsibilities." The documents said that "long-term care inspections" and the Ontario's "air ambulance service" Ornge would be "outsourced". According to a CTV News report, Minister Elliot was "forced to make assurances" that these services would not be "privatized".
Surgical technique – the nasolabial flap The pedicle of the nasolabial flap rests upon the lateral nasal wall, and is transposed a maximum of 60 degrees, in order to avoid the "bridge effect" of a flap emplaced across the nasofacial angle.
The field of AI safety is deeply intertwined with philosophical considerations, particularly in the realm of ethics. Deontological ethics, which emphasizes adherence to moral rules, has been proposed as a framework for aligning AI systems with human values. Some have suggested that by embedding deontological principles, AI systems can be guided to avoid actions that cause harm, ensuring their operations remain within ethical boundaries, but those suggestions have been questioned, with other alternatives being suggested as more promising.
Sources: en.wikipedia.org
==== Internationals that emerged from the Fourth International (USFI) ==== Fourth International Posadist (1962) Committee for a Workers' International, CWI (1974) refounded with the same name after a 2019 split. International Socialist Tendency, IST (1979) founded by expelled members of the original Fourth International in the 1950s International Workers League – Fourth International, IWL-FI (1982) founded by former members of the USFI. Current for the Permanent Revolution - Fourth International, CPR-FI (1989) Previously named Trotskyist Fraction - Fourth International. Founded by expelled members of the IWL-FI Pathfinder Tendency, (1990) based on USA SWP Revolutionary Communist International, RCI (1992). Split from CWI. Previously named International Marxist Tendency, IMT (2004–2024), and the Committee for a Marxist International, CMI (1992–2004) International Workers' Unity – Fourth International, IWU-FI (1997) split from IWL-FI. International Leninist Trotskyist Fraction, ILTF (1998) split from the TF-FI Tendency for the Reconstruction of the Fourth International, (2006) formed by expelled members of the TF-FI. International Revolutionary Left, (2010) split from IMT in 2010 and the CWI in 2019 Revolutionary Communist International Tendency, RCIT (2011) founded by former members of the IST and L5I. International Socialist League, ISL-LIS (2019) International Socialist Alternative, ISA (2020) claims to be successor to the CWI after the 2019 split. ISA-R ( external faction) Internationalist Standpoint, IS (2022) split from International Socialist Alternative.
==== First two playoff appearances (1997–98) ==== The 1,000th hit of Bagwell's career was a home run on May 20, 1997, off Calvin Maduro, one of his two that game, in a 9–5 win over the Philadelphia Phillies. He was selected to the play in the All-Star Game. Exhibiting above-average speed and baserunning skills for a first baseman, Bagwell became the first full-time first baseman to join the 30–30 club, capping the 1997 season with 31 steals in 41 attempts. The only other first baseman to accomplish the 30–30 club is Joe Carter. Bagwell batted .286 and scored 109 runs. He finished second in the league with both 43 home runs and 135 RBI, his career high in RBI. He was third in the MVP balloting. He made the playoffs for the first time in 1997 when the Astros won the National League Central division, the club's first appearance in 11 years. The Astros faced the Atlanta Braves in the National League Division Series (NLDS), who swept them in three games. Bagwell, Biggio and Bell combined for two hits in 37 at bats. In 1998, Bagwell informed a Houston Chronicle reporter that he was using androstenedione (commonly referred to as "andro"), which at the time the United States Food and Drug Administration (FDA) classified it as a nutritional dietary supplement, finding it benign and authorized for non-medicinal purposes. It was considered a "weak" androgen steroid hormone and allegedly in widespread use around the sport at the time.[c] Bagwell hit his first career grand slam while tying a career-high six RBI against Cincinnati on September 8 in a 13–7 victory.
Lewis Clayton Cantley (born February 20, 1949) is an American cell biologist and biochemist who has made significant advances to the understanding of cancer metabolism. Among his most notable contributions are the discovery and study of the enzyme PI-3-kinase, now known to be important to understanding cancer and diabetes mellitus. He was Meyer Director and Professor of Cancer Biology at the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine in New York City. He is a professor in the Departments of Systems Biology and Medicine at Harvard Medical School, and the Director of Cancer Research at the Beth Israel Deaconess Medical Center, in Boston, Massachusetts. In 2016, he was elected Chairman of the Board for the Hope Funds for Cancer Research.
Sutherland then studied the mechanism and foundthat the increased formation of phosphorylase in liver was mediated by a certain substance, later named cAMP. At the time, this was the only known physiological function of enzymatic phosphorylation, as a physiological control mechanism for one metabolic pathway, until 1969, when it was discovered that mitochondrial pyruvate dehydrogenase complex was inactivated by phosphorylation. Also in the 1970s, the term multisite phosphorylation was coined, to describe the new discovery that some proteins are phosphorylated on two or more residues by two or more kinases. In 1975, it was shown that cAMP-dependent proteins kinases phosphorylate serine residues on specific amino acid sequence motifs. Ray Erikson discovered that v-Src was a kinase and Tony Hunter found that v-Src phosphorylated tyrosine residues on proteins in the 1970s. In the early 1980, the amino-acid sequence of the first protein kinase was determined which helped geneticists understand the functions of regulatory genes. In the late 1980s and early 1990s, the first protein tyrosine phosphatase (PTP1B) was purified and the discovery, as well as, cloning of JAK kinases was accomplished which led to many in the scientific community to name the 1990s as the decade of protein kinase cascades. Edmond Fischer and Edwin Krebs were awarded the Nobel prize in 1992 "for their discoveries concerning reversible protein phosphorylation as a biological regulatory mechanism".
Sources: en.wikipedia.org
Mass spectrometry combined with liquid chromatography provides both molecular weight confirmation and a measure of related impurities. Tandem mass spectrometry adds sequence information. A purity percentage reported without a mass measurement does not confirm what the material is.
No. Lyophilisation slows degradation rather than stopping it, and the rate depends on residual moisture, temperature and light exposure. Freezer storage extends useful life but does not make the material permanent.
A certificate is only as good as its traceability to a specific batch and a named laboratory. Documents lacking batch numbers, method descriptions or laboratory identifiers carry little weight. Confirming what was actually received generally requires a separate test of the material in hand.
Low temperature slows hydrolysis and oxidation, the two main routes by which the peptide backbone and side chains are modified. A lyophilised powder stored at −20 °C is more stable than one kept at room temperature, and once the material is dissolved the degradation rate rises, making refrigeration more important.